SARS-CoV-2 RNA polymerase — Drug Target

All drugs that target SARS-CoV-2 RNA polymerase — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Nucleotide analog RNA polymerase inhibitor

Marketed (1)

• Veklury · Gilead Sciences · Nucleotide analog RNA polymerase inhibitor · Metabolic
  Remdesivir is an antiviral nucleotide analog RNA polymerase inhibitor with activity against SARS-CoV-2.